Andrew Peck

$2.4B Life Sciences Analytical Tools Company

• Launched new Biomedical Research business line extending core products into adjacent market
• Managed $30M newborn screening business including new product launch and build of partner network
• Grew clinical research business line 28% to $35M in first year with product alignment and targeted market campaigns
• Led business development efforts, identifying KOL and partner organizations to in-license content and technologies
• Negotiated contracts, structured deals, and worked with internal resources to align research and development efforts in established and novel diagnostic areas
• Elected to management team for executing corporate-wide restructuring
• Initiated summer MBA internship program

Start-up peptide biomarker discovery and development company

• Generated operational model, business plan, and investor presentation and executed venture capital roadshow, raising $1.5M in funding during ‘08-’09 financial market
• Managed executive and scientific teams as well as scientific, diagnostic, and company boards
• Developed collaborations with top medical research centers including Tufts Medical Center and Lahey Clinic
• Patented novel biomarkers for material and use

Peptide biomarker discovery company

• Led a team scientists in Germany, the Netherlands, and the U.S. to transform an academic biomarker discovery platform (HPLC/MALDI-TOF/QStar) into a commercial discovery product
• Led market research efforts for multiple therapeutic areas, including liver cancer, colorectal cancer, breast cancer, lupus, Alzheimer’s, and myocardial infarction, in support of successful commercialization efforts
• Developed and maintained strong partnerships with multiple top-seeded clinical research centers
• Crafted company market presence as well as product marketing and sales literature
• Host, speaker, and moderator at multiple VIP dinners for current and prospective customers; Provided scientific expertise for all business development efforts
• Co-authored Investment Memoranda and VC road show presentation; Scientific representative for funding series

Boutique strategy consultancy focused on improving the economies of pharmaceutical research and development.

• Launched and grew company based on portfolios focused on key functions in pharmaceutic R&D; Achieved profitability in 22 months; sold to CHI in 2006
• Launched and P&L responsibility for a primary source line of science & technology reports; generated and/or contracted content; initiated and managed affiliated author program; managed team of editors, graphical artists, production staff
• Planned, conducted, and analyzed primary and secondary research; Recruited and managed team of analysts
• Hosted and moderated multiple, invitation-only forums for clients; Presented data, analyses, results and recommendations; lead round table discussions and root-cause discussions with clients to identify new projects

Genomic data mining and visualization platform company

• Conducted market/financial analysis for lead product
• Managed engineering development team, supply chain, third party resellers/partners, hardware/software vendors
• Led all sales engagements and was key account manager for Fortune 500 pharmaceuticals and biotechnology companies
• Authored and secured $250K grant funding from the Genome Institute for participation in the HapMap project

• Planned, developed and executed all aspects of multiple research programs for NASA’s Mars Mission, exploring effects of altered gravitoinertal fields on human neurophysiology and coordination
• Trained both graduate and undergraduate students entering the lab through mentor program, seminars, and classes.

Awarded Distinguished Scientist Fellowship by American Psychology Association for Excellent in Scientific Research